Diagnostics & Research
The Diagnostics & Research industry has a total of 50 stocks, with a combined market cap of $789.29 billion, total revenue of $166.47 billion and a weighted average PE ratio of 52.78.
Market Cap
789.29B
Revenue
166.47B
Profits
14.96B
PE Ratio
52.78
Profit Margin
8.98%
Dividend Yield
0.18%
50 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 217.89B | 0.74% | 732,033 | 43.74B |
| 2 | DHR | Danaher Corporation | 163.05B | 1.24% | 1,868,634 | 24.27B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 54.48B | -2.82% | 586,333 | 4.17B |
| 4 | A | Agilent Technologies, Inc. | 39.22B | -0.12% | 1,208,713 | 6.95B |
| 5 | IQV | IQVIA Holdings Inc. | 38.34B | 0.35% | 711,795 | 15.90B |
| 6 | NTRA | Natera, Inc. | 32.56B | -0.07% | 1,003,865 | 2.12B |
| 7 | MTD | Mettler-Toledo International Inc. | 28.90B | 0.16% | 82,684 | 3.94B |
| 8 | WAT | Waters Corporation | 22.81B | -0.24% | 346,260 | 3.11B |
| 9 | LH | Labcorp Holdings Inc. | 20.99B | -0.75% | 657,623 | 13.77B |
| 10 | ILMN | Illumina, Inc. | 20.81B | -1.02% | 916,568 | 4.29B |
| 11 | DGX | Quest Diagnostics Incorporated | 19.48B | -0.71% | 652,768 | 10.85B |
| 12 | EXAS | Exact Sciences Corporation | 19.28B | -0.23% | 1,654,093 | 3.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 16.05B | -0.32% | 193,905 | 2.36B |
| 14 | ICLR | ICON Public Limited Company | 13.98B | 2.19% | 693,082 | 8.10B |
| 15 | GH | Guardant Health, Inc. | 13.21B | 1.14% | 1,485,370 | 902.57M |
| 16 | RVTY | Revvity, Inc. | 11.06B | -0.19% | 727,842 | 2.81B |
| 17 | CRL | Charles River Laboratories International, Inc. | 9.98B | -0.07% | 462,230 | 4.02B |
| 18 | QGEN | Qiagen N.V. | 9.89B | -0.96% | 1,015,400 | 2.07B |
| 19 | RDNT | RadNet, Inc. | 5.62B | -2.57% | 795,578 | 1.97B |
| 20 | SHC | Sotera Health Company | 4.95B | 0.75% | 2,293,544 | 1.15B |
| 21 | BLLN | BillionToOne, Inc. | 3.99B | -9.57% | 208,707 | 254.14M |
| 22 | WGS | GeneDx Holdings Corp. | 3.91B | -3.44% | 401,131 | 402.19M |
| 23 | GRAL | GRAIL, Inc. | 3.56B | -3.14% | 771,068 | 141.83M |
| 24 | VCYT | Veracyte, Inc. | 3.39B | -0.39% | 420,442 | 495.14M |
| 25 | TWST | Twist Bioscience Corporation | 2.07B | -3.48% | 804,731 | 376.57M |
| 26 | NEO | NeoGenomics, Inc. | 1.61B | 0.04% | 2,205,512 | 709.16M |
| 27 | NEOG | Neogen Corporation | 1.55B | 0.28% | 1,764,815 | 886.89M |
| 28 | CSTL | Castle Biosciences, Inc. | 1.17B | -2.88% | 225,612 | 343.53M |
| 29 | CDNA | CareDx, Inc | 1.03B | - | 501,254 | 358.00M |
| 30 | OPK | OPKO Health, Inc. | 1.01B | -1.50% | 2,295,195 | 642.07M |
| 31 | FLGT | Fulgent Genetics, Inc. | 839.58M | -1.74% | 195,484 | 315.55M |
| 32 | PSNL | Personalis, Inc. | 747.73M | -3.44% | 774,944 | 69.10M |
| 33 | MYGN | Myriad Genetics, Inc. | 611.48M | -2.96% | 498,791 | 825.30M |
| 34 | PRE | Prenetics Global Limited | 287.93M | -6.91% | 207,385 | 77.08M |
| 35 | BNR | Burning Rock Biotech Limited | 234.39M | -6.93% | 54,345 | 75.75M |
| 36 | MDXH | MDxHealth SA | 171.76M | 2.06% | 89,387 | 103.07M |
| 37 | IMDX | Insight Molecular Diagnostics Inc. | 155.07M | -2.70% | 24,418 | 4.40M |
| 38 | XGN | Exagen Inc. | 143.23M | -4.68% | 506,159 | 63.60M |
| 39 | FONR | FONAR Corporation | 95.12M | -2.29% | 27,555 | 105.43M |
| 40 | BDSX | Biodesix, Inc. | 53.70M | -0.88% | 26,678 | 80.17M |
| 41 | PRPO | Precipio, Inc. | 40.80M | 0.82% | 9,667 | 22.80M |
| 42 | NOTV | Inotiv, Inc. | 22.26M | -4.57% | 349,949 | 513.02M |
| 43 | MBAI | Check-Cap Ltd. | 10.47M | -3.24% | 41,139 | - |
| 44 | MYNZ | Mainz Biomed N.V. | 9.87M | 2.68% | 202,017 | 659.94K |
| 45 | ADVB | Advanced Biomed Inc. | 7.99M | 1.29% | 62,910 | - |
| 46 | NDRA | ENDRA Life Sciences Inc. | 5.95M | -2.30% | 7,581 | - |
| 47 | BIAF | bioAffinity Technologies, Inc. | 5.53M | -3.15% | 33,895 | 6.78M |
| 48 | ISPC | iSpecimen Inc. | 3.72M | 2.26% | 239,384 | 3.35M |
| 49 | XWEL | XWELL, Inc. | 3.59M | -5.44% | 4,091 | 29.52M |
| 50 | PRPH | ProPhase Labs, Inc. | 3.17M | -29.18% | 2,802,243 | 5.06M |